In an earlier study on pediatric B-ALL, CCN2 expression of lymphoblasts at diagnosis was not found to be predictive of relapse, as the same number of patients with a relapse had CCN2 expressing lymphoblasts at diagnosis as those in continued remission (Vorwerk et al. 2002). Here, CCN2 is linked to precursor B-cell acute lymphoblastic leukemia.